Mr. Maclean et al., PHOSPHODIESTERASE ISOFORMS IN THE PULMONARY ARTERIAL CIRCULATION OF THE RAT - CHANGES IN PULMONARY-HYPERTENSION, The Journal of pharmacology and experimental therapeutics, 283(2), 1997, pp. 619-624
Phosphodiesterase (PDE) activity was determined in pulmonary arteries
removed from control and chronic hypoxia-induced pulmonary hypertensiv
e rats. The main, first-branch, intrapulmonary and resistance pulmonar
y arteries were studied. We measured total cAMP PDE activity and cGMP
PDE activity, as well as that of individual isoforms (PDE1-5). cAMP PD
E activity in chronic hypoxic rats was increased in first-branch and i
ntrapulmonary arteries from hypoxic rats. No changes were observed in
the main or resistance pulmonary arteries. Similarly, cGMP PDE activit
y was increased in the main, first-branch and intra-pulmonary arteries
of the hypoxic rats. No changes in cGMP PDE activity were observed in
resistance arteries. There was evidence for PDE1-5 activity in all pu
lmonary arteries. The increased cAMP PDE activity in first-branch and
intrapulmonary vessels was associated with an increase in cilostimide-
inhibited PDE (PDE3) activity. increased total cGMP PDE in main pulmon
ary artery was associated with increases in Ca++/calmodulin-stimulated
(PDE1) activity. An increase in zaprinast-inhibited (PDE5) activity w
as observed in first-branch and intrapulmonary arteries. Our results s
uggest that decreases in intracellular cyclic nucleotide levels in pul
monary arteries from pulmonary hypertensive rats are associated with i
ncreased PDE activity. Further, these changes may reflect alterations
at the level of specific types of PDE isoforms.